Amedisys Reports Third Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys Reports Third Quarter Financial Results

Piper Jaffray Raises Price Target as Amedisys (AMED) Raises Acquisition Pipeline

November 6, 2015 11:44 AM EST

Piper Jaffray reiterated a Neutral rating on Amedisys (NASDAQ: AMED), and raised the price target to $45.00 (from $42.00), following the company's 3Q report. AMED's acquisition pipeline has increased from 17 potential targets a year ago to over 300. While deal valuations have increased to... More

Amedisys (AMED) Tops Q3 EPS by 1c

November 5, 2015 8:12 AM EST

Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $326.44 million versus the consensus estimate of $312.22 million.

Paul B. Kusserow, President and Chief Executive Officer stated, We are encouraged by the companys... More